[Ribosomal dysentery vaccine. II. Biological trials of active protection for guinea pigs and mice].
Ribosomal vaccine from Sh. sonnei injected subcutaneously once or twice in physiological saline or in Freund's complete adjuvant produces a marked protective effect against experimental keratoconjunctivitis in guinea pigs. Inhibition of the protective effect by high doses (above 100 microgram) of ribosomal vaccine is evident after a single, but not repeated injections. Protective effect in mice is achieved by immunization with very low doses of ribosomal vaccine: ED50 is 1.2 ng after challenge with 5.6 LD50. The nature of immunogenic factor responsible for the biological activity of the ribosome vaccine is still obscure. In contrast to Boivin's antigen, ribosomal preparations, even in high doses (1000--2000 microgram), have no toxic effect on mice and guinea pigs.
D000818:Animals; D001428:Bacterial Vaccines / Q000008:administration & dosage; D004405:Dysentery, Bacillary / Q000517:prevention & control*; D005260:Female; D006168:Guinea Pigs; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D007637:Keratoconjunctivitis / Q000517:prevention & control; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D012270:Ribosomes / Q000276:immunology; D012764:Shigella sonnei / Q000276:immunology*; D014611:Vaccination
D001428:Bacterial Vaccines
Ribosomal'naia dizenteriĭnaia vaktsina. Soobshchenie II. Biologicheskie ispytaniia v opytakh aktivnoĭ zashchity morskikh svinok i mysheĭ.